Dr. Joshua Ian Levinger, MD

Dr. Levinger practices at Memorial Medical Center in Las Cruces, New Mexico, part of Lifepoint Health.

Dr. Levinger's NPI, 1942456967, was assigned on August 10, 2008. Dr. Levinger graduated from Weill Cornell Medicine in 2005. Dr. Levinger holds Texas license S7908.

Dr. Levinger's primary practice is Memorial Medical Center, at 2450 South Telshor Blvd, Las Cruces, NM 88011 in Dona Ana County. The practice phone is (575) 522-8641.

Dr. Levinger's primary practice is Memorial Medical Center in Las Cruces, New Mexico, part of Lifepoint Health. Dr. Levinger is also affiliated with Medical Center Hospital. The medical group on file is MCH ProCare. Dmand AI also links Dr. Levinger to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levinger practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Levinger's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Levinger is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Levinger's licenses on file in 2 states: Texas and New York.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and swimmer's ear among the conditions Dr. Levinger treats.

CMS data shows 870 Medicare services from Dr. Levinger across 8 procedure codes in 2024, for 324 Medicare patients. Medicare paid $60,595 for them. Every service was in an office.

CMS counts 324 Medicare patients who saw Dr. Levinger in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Levinger's median patient age at 52, with 51% women.

In 2024, Dr. Levinger wrote 1,011 Medicare Part D claims for 308 patients. 99% of them were for generic drugs. CMS names the drug for 867 of them, across 19 drugs with 11 or more claims each, at $10,302 in total drug cost. In 2023, CMS named 504 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Levinger for performance year 2024, reported as part of a group. Dr. Levinger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Levinger, published from 2017 to 2020. The most frequent topics are Dacryocystorhinostomy and Lacrimal Duct Obstruction. Dr. Levinger's most frequent co-authors are Ashutosh Kacker, MD, Aaron Pearlman, MD and Abtin Tabaee, MD.

CMS Open Payments shows 83 general payments to Dr. Levinger from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $472.

Dmand AI lists 1 award for Dr. Levinger, most recently CMS Stage 1 EHR in 2013.

Dr. Levinger graduated from Weill Cornell Medicine in 2005.

Dr. Levinger is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.